{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137044520950784.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1128/jcm.02107-20"}},{"identifier":{"@type":"URI","@value":"https://journals.asm.org/doi/pdf/10.1128/JCM.02107-20"}}],"dc:title":[{"@value":"Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>The development of vaccines against SARS-CoV-2 would be greatly facilitated by the identification of immunological correlates of protection in humans. However, to date, studies on protective immunity have been performed only in animal models and correlates of protection have not been established in humans. Here, we describe an outbreak of SARS-CoV-2 on a fishing vessel associated with a high attack rate. Predeparture serological and viral reverse transcription-PCR (RT-PCR) testing along with repeat testing after return to shore was available for 120 of the 122 persons on board over a median follow-up of 32.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137044520950790","@type":"Researcher","foaf:name":[{"@value":"Amin Addetia"}],"jpcoar:affiliationName":[{"@value":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950791","@type":"Researcher","foaf:name":[{"@value":"Katharine H. D. Crawford"}],"jpcoar:affiliationName":[{"@value":"Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"},{"@value":"Department of Genome Sciences, University of Washington, Seattle, Washington, USA"},{"@value":"Medical Scientist Training Program, University of Washington, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950786","@type":"Researcher","foaf:name":[{"@value":"Adam Dingens"}],"jpcoar:affiliationName":[{"@value":"Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950788","@type":"Researcher","foaf:name":[{"@value":"Haiying Zhu"}],"jpcoar:affiliationName":[{"@value":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950789","@type":"Researcher","foaf:name":[{"@value":"Pavitra Roychoudhury"}],"jpcoar:affiliationName":[{"@value":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"},{"@value":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950785","@type":"Researcher","foaf:name":[{"@value":"Meei-Li Huang"}],"jpcoar:affiliationName":[{"@value":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"},{"@value":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950656","@type":"Researcher","foaf:name":[{"@value":"Keith R. Jerome"}],"jpcoar:affiliationName":[{"@value":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"},{"@value":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950657","@type":"Researcher","foaf:name":[{"@value":"Jesse D. Bloom"}],"jpcoar:affiliationName":[{"@value":"Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"},{"@value":"Department of Genome Sciences, University of Washington, Seattle, Washington, USA"},{"@value":"Howard Hughes Medical Institute, Seattle, Washington, USA"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044520950787","@type":"Researcher","foaf:name":[{"@value":"Alexander L. Greninger"}],"jpcoar:affiliationName":[{"@value":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA"},{"@value":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}]}],"contributor":[{"@id":"https://cir.nii.ac.jp/crid/1381137044520950784","@type":"Researcher","foaf:name":[{"@value":"Alexander J. McAdam"}],"role":"editor"}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00951137"},{"@type":"EISSN","@value":"1098660X"}],"prism:publicationName":[{"@value":"Journal of Clinical Microbiology"}],"dc:publisher":[{"@value":"American Society for Microbiology"}],"prism:publicationDate":"2020-10-21","prism:volume":"58","prism:number":"11","prism:startingPage":"10"},"reviewed":"false","dc:rights":["https://creativecommons.org/licenses/by/4.0/","https://journals.asm.org/non-commercial-tdm-license"],"url":[{"@id":"https://journals.asm.org/doi/pdf/10.1128/JCM.02107-20"}],"createdAt":"2020-08-24","modifiedAt":"2022-03-05","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360022307169975040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814750287104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1390008688855977472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Update: Drug treatment options for coronavirus disease 2019 (COVID-19)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390010776362400512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development and Evaluation about “2nd-wave” COVID-19 Vaccines"},{"@language":"ja","@value":"これからの新型コロナウイルスワクチンの開発・評価について"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1128/jcm.02107-20"},{"@type":"CROSSREF","@value":"10.1248/yakushi.21-00234-3_references_DOI_3TmM3JiC5nJe9bdqQ7HpU4FxQuR"},{"@type":"CROSSREF","@value":"10.5582/bst.2021.01346_references_DOI_3TmM3JiC5nJe9bdqQ7HpU4FxQuR"},{"@type":"CROSSREF","@value":"10.3390/antib12030060_references_DOI_3TmM3JiC5nJe9bdqQ7HpU4FxQuR"},{"@type":"CROSSREF","@value":"10.1016/j.heliyon.2024.e24513_references_DOI_3TmM3JiC5nJe9bdqQ7HpU4FxQuR"}]}